Prenetics(PRE)
Search documents
Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
Newsfilter· 2024-07-11 12:30
Beckham becomes a strategic investor in PreneticsBeckham and Prenetics are co-founding partners for IM8, a new health and wellness brand LOS ANGELES, July 11, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ:PRE) a leading health sciences company, is proud to announce that former international footballer, entrepreneur and philanthropist David Beckham has become a strategic investor in the business. Prenetics and Beckham will become co-founding partners of a new health and wellness brand, IM8, which will focus ...
Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors
Newsfilter· 2024-07-01 12:30
LOS ANGELES, July 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company, welcomes Kathryn M. Henry and David Vanderveen as independent directors to the Company's Board of Directors. "We are excited to welcome Kathryn and David to Prenetics' Board of Directors at this pivotal juncture," said Danny Yeung, CEO of Prenetics. "Their unparalleled expertise in consumer and health sectors, combined with their proven leadership in driving ...
Prenetics Announces First Quarter 2024 Financial Results
GlobeNewswire News Room· 2024-06-18 12:30
First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter Confirms Strategic Pivot Targeting the U.S. Consumer Healthcare Market Reaffirms 2024 Revenue Range of US$33 million to US$36 million LOS ANGELES, June 18, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced unaudited financial results for the first quarter ended March 31, 2024, along with recent business updates. Firs ...
Prenetics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
Newsfilter· 2024-06-17 12:30
LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, has engaged international investor relations specialists MZ Group ("MZ") to lead a comprehensive strategic investor relations and financial communications program across all key markets. MZ Group will work closely with Prenetics management to develop and implement a capital markets strategy designed to increase the Company's visibility throug ...
DYMO PARTNERS WITH TAYLOR TO OFFER CUSTOM PRE-PRINTED LABELS FOR DYMO LABELWRITER 5 SERIES PRINTERS
Prnewswire· 2024-06-05 13:01
ATLANTA, June 5, 2024 /PRNewswire/ -- DYMO®, a leading provider of innovative labeling solutions and part of the Newell Brands global portfolio, and Taylor, a renowned name in custom label manufacturing, have announced a strategic partnership that makes custom-printed LabelWriter® labels available for use with DYMO LabelWriter® 5 Series printers.(L) Joe Klenke, President, Taylor Labeling Solutions (M) Kris Malkoski, Segment CEO, Learning & Development, Newell Brands (R) Steve Mcdonell, Vice President of Eng ...
Prenetics(PRE) - 2023 Q4 - Annual Report
2024-04-30 21:37
Table of Contents _________________________ _________________________ _________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F _________________________ (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC ...
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station
Newsfilter· 2024-02-09 14:25
Core Insights - Prenetics Global Limited has signed a Memorandum of Understanding (MOU) with Metavisionaries and Space Application Services to establish a strategic investment and a five-year research agreement focused on space-related health advancements [1][2] - The initial research project will be conducted in collaboration with the Botnar Research Institute at the University of Oxford, targeting accelerated aging in space [2] - The first research cube from Prenetics is set to be launched aboard SpaceX to the International Space Station (ISS) in the fourth quarter of 2024 [1] Company Developments - Dr. James L. Green and Dr. Tara Ruttley, both former NASA scientists, will join the Prenetics Scientific Advisory Board, enhancing the company's expertise in space research [4] - Danny Yeung, CEO of Prenetics, will also join the Board of Directors at Metavisionaries, strengthening the strategic partnership [4] - Prenetics is committed to leveraging space research to drive health innovations on Earth, as stated by its CEO [3] Research Focus - The collaboration aims to explore cellular solutions that promote rejuvenation and combat accelerated aging caused by the zero-gravity environment of space [2] - The research has the potential to lead to significant advancements in healthcare, enhancing cellular health and longevity for individuals on Earth [2] Strategic Goals - The partnership is part of a broader initiative to build a space ecosystem by engaging non-space industry partners in innovation and exploration [2] - The establishment of a Space Innovation Lab within the UAE Space Agency is a key component of this initiative [1]
Prenetics(PRE) - 2023 Q2 - Quarterly Report
2023-06-29 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number 001-41401 Prenetics Global Limited Unit 701-706, K11 Atelier King's Road 728 King's Road, Quarry Bay Hong Kong (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Fo ...
Prenetics(PRE) - 2022 Q4 - Annual Report
2023-04-30 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ...